Dizhe Pharmaceuticals (688192.SH) two executives plan to collectively reduce their holdings by no more than 318,100 shares.

The Zhitong Finance and Economics APP News, Dizhi Medicine (688192.SH) announced that Ms. Wu Qingyi plans to reduce her holdings by no more than 30.21 million shares (including this number) through centralized bidding, accounting for no more than 0.0657% of the company's total share capital, and no more than 25% of the company's shares held by her before this reduction; Dr. Chang Shih-Ying plans to reduce his holdings by no more than 16,000 shares (including this number) through centralized bidding, accounting for no more than 0.0035% of the company's total share capital, and no more than 25% of the company's shares held by him before this reduction. The reduction period is from June 24, 2025 to September 23, 2025, and the reduction price will be determined based on the market price during the reduction implementation period.